Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 August 2003:
Vol. 301. no. 5635, pp. 967 - 969
DOI: 10.1126/science.1086187
Prev | Table of Contents | Next

Reports

SCNM1, a Putative RNA Splicing Factor That Modifies Disease Severity in Mice

David A. Buchner, Michelle Trudeau, Miriam H. Meisler*

The severity of many inherited disorders is influenced by genetic background. We describe a modifier interaction in C57BL/6Jmice that converts a chronic movement disorder into a lethal neurological disease. The primary mutation (medJ) changes a splice donor site of the sodium channel gene Scn8a (Nav1.6). The modifier mutation is characteristic of strain C57BL/6Jand introduces a nonsense codon into sodium channel modifier 1 (SCNM1), a zinc finger protein and a putative splice factor. An internally deleted SCNM1 protein is also predicted as a result of exon skipping associated with disruption of a consensus exonic splicing enhancer. The effect of the modifier mutation is to reduce the abundance of correctly spliced sodium channel transcripts below the threshold for survival. Our finding that genetic variation in a putative RNA splicing factor influences disease susceptibility in mice raises the possibility that a similar mechanism modifies the severity of human inherited disorders.

Department of Human Genetics, University of Michigan School of Medicine, Ann Arbor, MI 48109–0618, USA.

* To whom correspondence should be addressed. E-mail: meislerm{at}umich.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The ataxia3 Mutation in the N-Terminal Cytoplasmic Domain of Sodium Channel Nav1.6 Disrupts Intracellular Trafficking.
L. M. Sharkey, X. Cheng, V. Drews, D. A. Buchner, J. M. Jones, M. J. Justice, S. G. Waxman, S. D. Dib-Hajj, and M. H. Meisler (2009)
J. Neurosci. 29, 2733-2741
   Abstract »    Full Text »    PDF »
A Targeted Deleterious Allele of the Splicing Factor SCNM1 in the Mouse.
V. M. Howell, G. de Haan, S. Bergren, J. M. Jones, C. T. Culiat, E. J. Michaud, W. N. Frankel, and M. H. Meisler (2008)
Genetics 180, 1419-1427
   Abstract »    Full Text »    PDF »
Genetic Modification of the Schisis Phenotype in a Mouse Model of X-Linked Retinoschisis.
B. A. Johnson, N. Aoyama, N. H. Friedell, S. Ikeda, and A. Ikeda (2008)
Genetics 178, 1785-1794
   Abstract »    Full Text »    PDF »
The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
M. S. Martin, B. Tang, L. A. Papale, F. H. Yu, W. A. Catterall, and A. Escayg (2007)
Hum. Mol. Genet. 16, 2892-2899
   Abstract »    Full Text »    PDF »
Evidence for a direct role of the disease modifier SCNM1 in splicing.
V. M. Howell, J. M. Jones, S. K. Bergren, L. Li, A. C. Billi, M. R. Avenarius, and M. H. Meisler (2007)
Hum. Mol. Genet. 16, 2506-2516
   Abstract »    Full Text »    PDF »
The impact of alternative splicing in vivo: Mouse models show the way.
T. Moroy and F. Heyd (2007)
RNA 13, 1155-1171
   Abstract »    Full Text »    PDF »
Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene.
H. L. Lemmerhirt, J. A. Shavit, G. G. Levy, S. M. Cole, J. C. Long, and D. Ginsburg (2006)
Blood 108, 3061-3067
   Abstract »    Full Text »    PDF »
Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles.
P. Liao, T. F. Yong, M. C. Liang, D. T. Yue, and T. W. Soong (2005)
Cardiovasc Res 68, 197-203
   Abstract »    Full Text »    PDF »
Determinants of the inherent strength of human 5' splice sites.
X. ROCA, R. SACHIDANANDAM, and A. R. KRAINER (2005)
RNA 11, 683-698
   Abstract »    Full Text »    PDF »
A Novel Mutation of COL2A1 Resulting in Dominantly Inherited Rhegmatogenous Retinal Detachment.
A. J. Richards, S. Meredith, A. Poulson, P. Bearcroft, G. Crossland, D. M. Baguley, J. D. Scott, and M. P. Snead (2005)
Invest. Ophthalmol. Vis. Sci. 46, 663-668
   Abstract »    Full Text »    PDF »
Nonsense-associated alternative splicing of T-cell receptor {beta} genes: No evidence for frame dependence.
F. MOHN, M. BUHLER, and O. MUHLEMANN (2005)
RNA 11, 147-156
   Abstract »    Full Text »    PDF »
Alternative splicing induced by nonsense mutations in the immunoglobulin {micro} VDJ exon is independent of truncation of the open reading frame.
M. BUHLER and O. MUHLEMANN (2005)
RNA 11, 139-146
   Abstract »    Full Text »    PDF »
Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator.
C. E. Keegan, J. E. Hutz, T. Else, M. Adamska, S. P. Shah, A. E. Kent, J. M. Howes, W. G. Beamer, and G. D. Hammer (2005)
Hum. Mol. Genet. 14, 113-123
   Abstract »    Full Text »    PDF »
A survey of splice variants of the human hypoxanthine phosphoribosyl transferase and DNA polymerase beta genes: products of alternative or aberrant splicing?.
A. Skandalis and E. Uribe (2004)
Nucleic Acids Res. 32, 6557-6564
   Abstract »    Full Text »    PDF »
Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6.
B. T. MacDonald, M. Adamska, and M. H. Meisler (2004)
Development 131, 2543-2552
   Abstract »    Full Text »    PDF »
LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome.
K Fukuchi, T Katsuya, K Sugimoto, M Kuremura, H D Kim, L Li, and T Ogihara (2004)
J. Med. Genet. 41, e67
   Full Text »    PDF »
Rescue of a human mRNA splicing defect by the plant cytokinin kinetin.
S. A. Slaugenhaupt, J. Mull, M. Leyne, M. P. Cuajungco, S. P. Gill, M. M. Hims, F. Quintero, F. B. Axelrod, and J. F. Gusella (2004)
Hum. Mol. Genet. 13, 429-436
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)